1. Home
  2. WST vs EQH Comparison

WST vs EQH Comparison

Compare WST & EQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • EQH
  • Stock Information
  • Founded
  • WST 1923
  • EQH 1859
  • Country
  • WST United States
  • EQH United States
  • Employees
  • WST N/A
  • EQH N/A
  • Industry
  • WST Medical/Dental Instruments
  • EQH Specialty Insurers
  • Sector
  • WST Health Care
  • EQH Finance
  • Exchange
  • WST Nasdaq
  • EQH Nasdaq
  • Market Cap
  • WST 20.1B
  • EQH 16.2B
  • IPO Year
  • WST N/A
  • EQH N/A
  • Fundamental
  • Price
  • WST $270.69
  • EQH $44.40
  • Analyst Decision
  • WST Strong Buy
  • EQH Buy
  • Analyst Count
  • WST 9
  • EQH 11
  • Target Price
  • WST $354.50
  • EQH $64.45
  • AVG Volume (30 Days)
  • WST 723.3K
  • EQH 2.8M
  • Earning Date
  • WST 10-23-2025
  • EQH 11-04-2025
  • Dividend Yield
  • WST 0.32%
  • EQH 2.41%
  • EPS Growth
  • WST 0.17
  • EQH N/A
  • EPS
  • WST 6.75
  • EQH N/A
  • Revenue
  • WST $3,017,900,000.00
  • EQH $12,337,000,000.00
  • Revenue This Year
  • WST $6.97
  • EQH $17.79
  • Revenue Next Year
  • WST $6.11
  • EQH $3.00
  • P/E Ratio
  • WST $40.78
  • EQH N/A
  • Revenue Growth
  • WST 4.92
  • EQH 17.15
  • 52 Week Low
  • WST $187.43
  • EQH $41.39
  • 52 Week High
  • WST $348.90
  • EQH $56.61
  • Technical
  • Relative Strength Index (RSI)
  • WST 48.03
  • EQH 29.15
  • Support Level
  • WST $262.48
  • EQH $44.84
  • Resistance Level
  • WST $287.98
  • EQH $49.57
  • Average True Range (ATR)
  • WST 11.36
  • EQH 1.22
  • MACD
  • WST -1.88
  • EQH -0.28
  • Stochastic Oscillator
  • WST 17.60
  • EQH 3.68

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About EQH Equitable Holdings Inc.

Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.

Share on Social Networks: